Adherence to 2021 ABS imaging recommendations in 148 male breast referrals at a UK hospital

This study was a retrospective observational cohort investigation conducted at King George Hospital in the UK. It involved a population of 148 male patients who were referred to the symptomatic breast clinic. The primary focus was on adherence to the 2021 ABS imaging recommendations for conditions including male breast cancer, gynaecomastia, and benign breast pathologies. The comparator was the 2021 ABS guidance itself, with a follow-up period of one year.

The provided input data did not include specific main results, numerical outcomes, or detailed findings regarding the primary outcome of adherence. Consequently, no specific statistics or efficacy data can be presented. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported in the source information.

Key limitations regarding the study design, funding, conflicts of interest, and specific constraints on interpretation were not reported. The practice relevance and causality notes were also not provided. Therefore, the clinical relevance of these findings remains unclear based on the available information. Caution is advised when interpreting this study due to the lack of reported outcome data and the observational nature of the design.